First published online January 25, 2008
doi: 10.1242/10.1242/dev.013623
Development 135, 659-667 (2008)
Published by The Company of Biologists 2008
The netrin receptor UNC5B promotes angiogenesis in specific vascular beds
Sutip Navankasattusas1,*,
Kevin J. Whitehead1,2,*,
Arminda Suli3,
Lise K. Sorensen1,
Amy H. Lim3,
Jia Zhao1,
Kye Won Park1,
,
Joshua D. Wythe1,4,
Kirk R. Thomas1,5,
Chi-Bin Chien3,6,
and
Dean Y. Li1,2,4,
1 Program in Human Molecular Biology and Genetics, University of Utah, Salt Lake
City, UT 84112, USA.
2 Division of Cardiology, Department of Internal Medicine, University of Utah,
Salt Lake City, UT 84112, USA.
3 Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT
84112, USA.
4 Department of Oncological Sciences, University of Utah, Salt Lake City, UT
84112, USA.
5 Division of Hematology, Department of Internal Medicine, University of Utah,
Salt Lake City, UT 84112, USA.
6 Brain Institute, University of Utah, Salt Lake City, UT 84112, USA.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 1. Vascular ablation of Unc5b impacts labyrinthine arterioles. Embryos
were harvested at E12.0 from Unc5bflox/flox x
Unc5b+/-; Tg(Tie2-Cre)/Tg(Tie2-Cre) (A-D),
Unc5b+/-;R26R [Rosa26 Reporter
(Soriano, 1999 )] x
Unc5b+/-; Tg(Tie2-Cre)/Tg(Tie2-Cre)
(E,F) or Unc5b+/- x
Unc5b+/- (G-J) matings. Placentas were dissected,
formalin fixed, hemisected and stained for: smooth muscle actin (anti-smooth
muscle actin antibody followed by HRP-conjugated secondary antibody) to
identify smooth muscle cells surrounding the arterial bed (A-D); for
β-galactosidase activity (X-gal) to identify endothelial expression of
Tie2-Cre (E,F); and for Pecam l (anti-Pecam1 antibody followed by
HRP-conjugated secondary antibody) to highlight the endothelium (G,H). There
is a decrease in the number of robust vertical vessel stalks in placentas
lacking UNC5B (B,D,F,H) when compared with their littermate controls
(A,C,E,G). This is also shown in I,J, which represent 10 µm cross-sections
through samples stained for smooth muscle actin. Arterioles are indicated by
arrows; scale bars: 0.5 mm. (K) The number of arterioles per placenta
was determined by serial sectioning (10 µm) of hemisected placentas,
staining for smooth muscle actin and visually counting all vessels. Paired
littermates (three pairs) representing each of the two genotypes were used for
all measurements. Error bars are standard deviation.
|
|

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 2. Physiological assessment of embryos. (A) Doppler flow
analysis of umbilical arteries and hearts in utero. For longitudinal follow-up
of umbilical artery Doppler flow, Unc5b+/flox;
+/Tg(Tie2-Cre) and
Unc5b-/flox;+/Tg(Tie2-Cre) embryos were monitored
on E12 at the time intervals indicated on the left. The ratio of diastolic (D)
flow (time velocity integral) over systolic (S) flow is shown as a percentage
with a negative number indicative of reverse flow. The ratio decreased
progressively over time in the mutant embryo and preceded pericardial effusion
(arrows) and bradycardia. (B) Quantitation of umbilical artery
diastolic flow reversal. The ratio of umbilical diastolic flow (time velocity
integral) over systolic flow was used to quantitate the degree of end
diastolic reverse flow and the ratio of -25% of systolic flow (broken line)
was chosen as a threshold for significant reversal; 24
Unc5b+/flox; +/Tg(Tie2-Cre) and 23
Unc5b-/flox;+/Tg(Tie2-Cre) embryos were sampled
at a single time point at E12.5. (C) The stroke volume, heart rate and
cardiac output were recorded at the onset of significant diastolic reverse
flow; data from four Unc5b+/flox; +/Tg(Tie2-Cre)
and three Unc5b-/flox;+/Tg(Tie2-Cre) are
reported; error bars are standard deviation. (D,E) Increased
hypoxia in Unc5b-/-embryos. Pregnant females were injected
with pimonidazole 2 hours prior to sacrifice and removal of embryos. Sections
(10 µm) from the hindbrain region of E12.5 Unc5b+/- (D)
and Unc5b-/- (E) embryos were probed with antibodies
directed against pimonidazole and HRP-conjugated secondary antibodies, stained
for HRP activity (brown, indicated by arrows) and counterstained with
hematoxylin (blue). V, trigeminal ganglion. Scale bar: 100 µm.
|
|

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 3. Unc5b/Netrin signaling in the placenta. (A,B)
Unc5b mRNA localization in the labyrinth. Placentas from E12.5
embryos were hemisected and probed with antisense RNA complementary to
Unc5b mRNA. (A)
Unc5b+/flox;+/Tg(Tie2-Cre) and (B)
Unc5b-/flox; +/Tg(Tie2-Cre); L indicates extent
of labyrinthine layer. Scale bars: 1 mm. (C,D) Netrin expression
in giant trophoblast cells. Placentas (E12.5) from embryos heterozygous for
the netrin1:lacZ gene trap
(Serafini et al., 1996 ) were
fixed, hemisected and stained with X-gal to detect lacZ activity; 10
µm sections were mounted on slides and counterstained with nuclear Fast
Red. L, labyrinth; S, spongiotrophoblast; G, giant trophoblast cell layer.
Image in D is a 4x magnification of boxed area in C. Scale bars: 200
µm in C; 100 µm in D. (E) Growth of umbilical vessels in vitro.
Umbilical vessels at E10.5 were explanted into collagen gels and allowed to
sprout for 10 days in the presence or absence of netrin 1 protein. Numbers of
sprouts were counted under phase contrast. Genotypes and growth conditions are
indicated above each frame. (F) Quantitation from four pairs of
umbilical arteries of each genotype. Error bars are standard deviation.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4. Knockdown of zebrafish unc5b prevents formation of a specific
vessel: the PAV. (A-D) Bright-field images of live embryos,
anterior towards the left. Overall trunk morphology is normal in
unc5b morphants (1 ng unc5bSBMO1 or 4 ng
unc5bSBMO2) compared with controls (uninjected or 8 ng control MO).
(E-H) Confocal projections of fli:egfp transgenics (reverse
contrast) show that unc5b knockdown prevents PAV formation. Lateral
views of somites 7-11, anterior towards the left; confocal projections through
entire trunk. Embryos imaged live (G,H) or fixed after anti-GFP staining
(E,F). (E,G) In uninjected embryos or control morphants at 48 hpf, almost
every hemisegment is spanned by a PAV at the horizontal myoseptum (red
arrows). (F,H) In embryos injected with either of two unc5b
splice-blocking MOs, PAVs are absent (blue arrows) or only partially span
their hemisegment (green arrows). DA, dorsal aorta; PCV, posterior
cardinal vein. (I,J) PAV formation scored as percentage of
hemisegments per embryo. In controls, at least 98% of hemisegments have
complete or partial PAVs; this fraction is drastically reduced by either
unc5b MO. n=25-30 embryos per condition;
**P<0.0001. Bars show mean±s.e.m. (K)
Partial unc5b genomic structure (not to scale), showing 5' UTR
(gray box), coding exons (white boxes) and MO targets. Scale bars: 1 mm in A
for A-D; 50 µm in E for E-H.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2008